| Editorial Board Members |
Prof. Najib Al Khaja – Founding Editor
Prof. Harald Rosen – Editor in Chief
Prof. Abdul Jabbar Mehdi – Editor
Prof. Fikri Abdu Zidan – Statistical Editor
Prof. Muscat Baron – Language Editor
Prof. Mathias Von Herrath – Member
Mr. ST Irwin – Member
Dr. Simon Bernard Dover – Member
Mr. Pradip K Datta – Member
Prof.Frederick Francis Fenech – Member
Prof. Sehamuddin Galadari – Member
Dr. Phillippe Macaire – Member
Dr. Rabah Showky – Member
Dr. Fahd Al Mulla – Member
Prof. Mona Al Rukhaimi – Member
Dr. Ghazi O Tadmouri – Member
|
| Additional Board Members |
Dr. Robert D. Madoff
Dr. Bernhard Ludvik
Dr. Nicolas Demartines
Dr. Hans Malus
Dr. Christoph Zielinski
Dr. Berit Schneider-Stickler
Prof. Thomas Binder
|
|
|
|
Neonatal Sepsis In The Very Low Birth Weight Preterm Infants
by Dr. Khalid N Haque
Over the last fifty years neonatal care has made tremendous progress; increasing survival, reducing morbidity, developing newer modalities of care and therapy for the very low birth weight (VLBW) and ...read more > |
Latest Articles & Publications
by Shyam
1. A Word in the Transitions : Managig the transfer pricing implications of complex supply chains.
2. Pressure to act now - New US Rules for Resolutions Plans
3. Yuvodoo - Booer Video - Road to Durbanread more > |
Heart Rate And Qt Interval In Streptozotocin-induced Diabetic Rat
by Mr. Chris Howarth
Prolonged QT interval is a common finding in diabetic patients. The effects of streptozotocin (STZ) induced diabetes on QT interval has been investigated by application of 4 standard QT correction algorithms. The electrocardiogram was recorded in STZ-treated (60 mg/kg bodyweight, ip) and age-matched control rats with a biotelemetry system for the period of the study. Heart rate (HR) was significantly (P < 0.01) reduced and QT interval was signifycantly (P < 0.05) prolonged in diabetic rats compared to controls at 8, 10 and 12 weeks after STZ treatment.
read more > |
|
|
|
Modulation Of Serine Proteases-mediated Platelet Activation By Novel Direct Thrombin Inhibitors
by Dr. Sarfraz Ahmad
Novel direct thrombin inhibitors (DTIs), such as bivalirudin, are replacing heparin in several clinical scenarios. In particular, DTIs are indicated for the treatment and thromboprophylaxis of patient...read more > |
|
|
|
